KKR to invest in Indian drugmaker Gland Pharma - Reuters

KKR has agreed to invest about $200 million in Indian drugmaker Gland Pharma Ltd, writes Reuters. Under the deal, KKR will acquire a minority holding in Gland Pharma, including the stake held by private equity fund Evolvence India Life Science Fund. The size of the stake was not disclosed.

DealsNorth AmericaUSBriefs